Abbreviations ASCVD: Atherosclerotic cardiovascular disease BMI: Body mass index CI: Confidence interval CKD: Chronic kidney disease CVD: Cardiovascular disease eGFR: Estimated glomerular filtration ratio GLP-1RA: Glucagon-like peptide-1 receptor agonist HFpEF: Heart failure with preserved ejection fraction HFrEF: Heart failure with reduced ejection fraction HHF: Heart failure hospitalization HR: Hazard ratio LDL: Low-density lipoprotein LVEF: Left ventricular ejection fraction MACE: Major cardiovascular events MRA: Mineralocorticoid receptor antagonist SGLT2: Sodium-glucose cotransporter 2 References Wong ND, Sattar N
In a recent randomized, double-blind, placebo-controlled trial, obese adults without diabetes were assigned to the exercise group, the GLP-1RA (Lira) group, and the exercise+Lira group
Q7: Should IGF-1 LR3 be injected SubQ or IM
This feature presents Lonzas recent research into L-carnitine tartrate, which has immunomodulatory effects that might influence the management of infectious diseases, including coronavirus disease 2019 (COVID-19)
Clinical Perspective "GLP-1 medications can offer real short-term benefits in terms of appetite reduction and early weight loss, but it is important to have realistic expectations about what happens when stopping GLP-1 medication," says Alessandro Grenci, Superintendent Pharmacist at Medino
They also include different formulations, delivery devices, and combinations with other drugs